Zeitschriftenartikel zum Thema „Opioid Use Disorder Market Share“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Opioid Use Disorder Market Share" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Alías-Ferri, Maria, Manuela Pellegrini, Emilia Marchei, Roberta Pacifici, Maria Concetta Rotolo, Simona Pichini, Clara Pérez-Mañá et al. „New Psychoactive Substances Consumption in Opioid-Use Disorder Patients“. Biology 11, Nr. 5 (22.04.2022): 645. http://dx.doi.org/10.3390/biology11050645.
Der volle Inhalt der QuelleKavanaugh, Philip R., und Katherine McLean. „Motivations for Diverted Buprenorphine Use in a Multisite Qualitative Study“. Journal of Drug Issues 50, Nr. 4 (22.07.2020): 550–65. http://dx.doi.org/10.1177/0022042620941796.
Der volle Inhalt der QuelleGedeon, Charlotte, Mikael Sandell, Inge Birkemose, Johan Kakko, Valgerður Rúnarsdóttir, Kaarlo Simojoki, Thomas Clausen, Fred Nyberg, Richard Littlewood und Hannu Alho. „Standards for opioid use disorder care: An assessment of Nordic approaches“. Nordic Studies on Alcohol and Drugs 36, Nr. 3 (27.01.2019): 286–98. http://dx.doi.org/10.1177/1455072518815322.
Der volle Inhalt der QuelleSivolap, Yury P. „Opioid crisis in the USA and Canada: how and why did this happen?“ Neurology Bulletin LV, Nr. 4 (15.01.2024): 18–24. http://dx.doi.org/10.17816/nb623231.
Der volle Inhalt der QuelleLi, Zhengyi, Xiangyu Du, Xiaojing Liao, Xiaoqian Jiang und Tiffany Champagne-Langabeer. „Demystifying the Dark Web Opioid Trade: Content Analysis on Anonymous Market Listings and Forum Posts“. Journal of Medical Internet Research 23, Nr. 2 (17.02.2021): e24486. http://dx.doi.org/10.2196/24486.
Der volle Inhalt der QuelleBlum, Kenneth, Abdalla Bowirrat, Eric R. Braverman, David Baron, Jean Lud Cadet, Shan Kazmi, Igor Elman et al. „Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions“. International Journal of Environmental Research and Public Health 18, Nr. 21 (02.11.2021): 11529. http://dx.doi.org/10.3390/ijerph182111529.
Der volle Inhalt der QuelleAhmedani, Brian K. „Policies and Events Affecting Prescription Opioid Use for Non-Cancer Pain Among an Insured Patient Population“. Pain Physician 3;17, Nr. 3;5 (14.05.2014): 205–16. http://dx.doi.org/10.36076/ppj.2014/17/205.
Der volle Inhalt der QuelleRenfro, Mandy L., Lindsey J. Loera, Carlos F. Tirado und Lucas G. Hill. „Lofexidine for acute opioid withdrawal: A clinical case series“. Mental Health Clinician 10, Nr. 5 (01.09.2020): 259–63. http://dx.doi.org/10.9740/mhc.2020.09.259.
Der volle Inhalt der QuelleTrinidad, Antolin C., und Benjamin Bregman. „Pharmacotherapy of Major Depressive Disorder: Focus on Desvenlafaxine Succinate“. Clinical Medicine Insights: Therapeutics 2 (Januar 2010): CMT.S74. http://dx.doi.org/10.4137/cmt.s74.
Der volle Inhalt der QuelleNakamoto, Carter H., Haiden A. Huskamp, Julie M. Donohue, Michael L. Barnett, Adam J. Gordon und Ateev Mehrotra. „Medicare Payment for Opioid Treatment Programs“. JAMA Health Forum 5, Nr. 7 (19.07.2024): e241907. http://dx.doi.org/10.1001/jamahealthforum.2024.1907.
Der volle Inhalt der QuelleCarlyle, Molly, Megan Rowley, Tobias Stevens, Anke Karl und Celia J. A. Morgan. „Impaired empathy and increased anger following social exclusion in non-intoxicated opioid users“. Psychopharmacology 237, Nr. 2 (05.11.2019): 419–30. http://dx.doi.org/10.1007/s00213-019-05378-x.
Der volle Inhalt der QuelleWerner, N., und J. P. Kahn. „Suicidology and Substance abuse in Adolescence“. European Psychiatry 24, S1 (Januar 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70524-3.
Der volle Inhalt der QuelleLemansky, Matthew G., Anna K. Martin, Judith A. Bernstein und Sabrina A. Assoumou. „Research Compensation and Enhanced Contacts in Studies With Persons Who Use Drugs: Lessons From the COVID-19 Pandemic Demand a Reset“. Substance Abuse: Research and Treatment 17 (Januar 2023): 117822182311790. http://dx.doi.org/10.1177/11782218231179039.
Der volle Inhalt der QuelleVoss, ScD, Maren Wright, Ashley C. Yaugher, PhD, Kandice Atismé, MHA, MPH und Amy Campbell, MPH. „Opioid misuse viewed through person and place in the rural West“. Journal of Opioid Management 18, Nr. 2 (01.03.2022): 151–59. http://dx.doi.org/10.5055/jom.2022.0705.
Der volle Inhalt der QuelleKnopf, Alison. „FDA approves first genetic test to help identify risk for OUD“. Alcoholism & Drug Abuse Weekly 36, Nr. 2 (07.01.2024): 8. http://dx.doi.org/10.1002/adaw.33990.
Der volle Inhalt der QuelleSolmeyer, Anna R., Aaron T. Berger, Sean L. Barton, Benjamin Nguyen, Gavin B. Bart, Brian Grahan, Heather J. Bell, Kurt M. DeVine und Weston Merrick. „Association of Project ECHO Training With Buprenorphine Prescribing by Primary Care Clinicians in Minnesota for Treating Opioid Use Disorder“. JAMA Health Forum 3, Nr. 11 (18.11.2022): e224149. http://dx.doi.org/10.1001/jamahealthforum.2022.4149.
Der volle Inhalt der QuelleKatz, Naomi T., Martyn Lloyd-Jones, Lucy Demediuk, Kerry McLaughlin, Megan McKechnie und Michelle Gold. „A Case Study of Pain Management at End-of-Life for a Patient on High-Dose Buprenorphine“. Journal of Patient Experience 9 (Januar 2022): 237437352210791. http://dx.doi.org/10.1177/23743735221079141.
Der volle Inhalt der QuelleWaselewski, Marika Elise, Tabor Elisabeth Flickinger, Chelsea Canan, William Harrington, Taylor Franklin, Kori Nicole Otero, Jacqueline Huynh et al. „A Mobile Health App to Support Patients Receiving Medication-Assisted Treatment for Opioid Use Disorder: Development and Feasibility Study“. JMIR Formative Research 5, Nr. 2 (23.02.2021): e24561. http://dx.doi.org/10.2196/24561.
Der volle Inhalt der QuelleMelnick, Edward R., Wesley C. Holland, Osama M. Ahmed, Anthony K. Ma, Sean S. Michael, Howard S. Goldberg, Christian Lagier et al. „An integrated web application for decision support and automation of EHR workflow: a case study of current challenges to standards-based messaging and scalability from the EMBED trial“. JAMIA Open 2, Nr. 4 (14.10.2019): 434–39. http://dx.doi.org/10.1093/jamiaopen/ooz053.
Der volle Inhalt der QuelleRoomruangwong, Chutima, Denitsa S. Simeonova, Drozdstoy S. Stoyanov, George Anderson, Andre Carvalho und Michael Maes. „Common Environmental Factors May Underpin the Comorbidity Between Generalized Anxiety Disorder and Mood Disorders Via Activated Nitrooxidative Pathways“. Current Topics in Medicinal Chemistry 18, Nr. 19 (21.12.2018): 1621–40. http://dx.doi.org/10.2174/1568026618666181115101625.
Der volle Inhalt der QuelleRandhawa, Privia A., Rupinder Brar und Seonaid Nolan. „Buprenorphine–naloxone “microdosing”: an alternative induction approach for the treatment of opioid use disorder in the wake of North America’s increasingly potent illicit drug market“. Canadian Medical Association Journal 192, Nr. 3 (19.01.2020): E73. http://dx.doi.org/10.1503/cmaj.74018.
Der volle Inhalt der QuelleCassidy, MPH, Theresa A., Eileen Thorley, MPH, Ryan A. Black, PhD, Angela DeVeaugh-Geiss, PhD, Stephen F. Butler, PhD und Paul Coplan, ScD. „Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder“. Journal of Opioid Management 13, Nr. 6 (07.12.2017): 425. http://dx.doi.org/10.5055/jom.2017.0419.
Der volle Inhalt der QuelleReddy, Julia, Kristel Black, Keia Bazemore, Kiva Jordan, Jamie B. Jackson und Andrea K. Knittel. „Ethical inclusion: Risks and benefits of research from the perspective of perinatal people with opioid use disorders who have experienced incarceration“. PLOS ONE 18, Nr. 11 (22.11.2023): e0294604. http://dx.doi.org/10.1371/journal.pone.0294604.
Der volle Inhalt der QuelleYoung, April M., Kathryn E. Lancaster, Sarann Bielavitz, Miriam R. Elman, Ryan R. Cook, Gillian Leichtling, Edward Freeman et al. „Peer-based Retention Of people who Use Drugs in Rural Research (PROUD-R2): a multisite, randomised, 12-month trial to compare efficacy of standard versus peer-based approaches to retain rural people who use drugs in research“. BMJ Open 12, Nr. 6 (Juni 2022): e064400. http://dx.doi.org/10.1136/bmjopen-2022-064400.
Der volle Inhalt der QuelleSharif, Omar, Madhusudan Basak, Tanzia Parvin, Ava Scharfstein, Alphonso Bradham, Jacob T. Borodovsky, Sarah E. Lord und Sarah M. Preum. „Characterizing Information Seeking Events in Health-Related Social Discourse“. Proceedings of the AAAI Conference on Artificial Intelligence 38, Nr. 20 (24.03.2024): 22350–58. http://dx.doi.org/10.1609/aaai.v38i20.30241.
Der volle Inhalt der QuelleFrancis, Erica, Jennifer Kraschnewski, Ruth Hogentogler, Kimberly Buckner, Jackie Sabol und Kara Bowers. „4060 A Telehealth Approach to Improving Healthcare to Rural and Underserved Populations“. Journal of Clinical and Translational Science 4, s1 (Juni 2020): 56. http://dx.doi.org/10.1017/cts.2020.199.
Der volle Inhalt der QuelleChorniy, Sofiia, Yaroslav Bilyk, Bohdana Pavliuk und Iryna Stechyshyn. „Analysis of the assortment structure of antidepressants on the domestic pharmaceutical market“. Ukrainian Scientific Medical Youth Journal 136, Nr. 1 (15.03.2023): 111–17. http://dx.doi.org/10.32345/usmyj.1(136).2023.111-117.
Der volle Inhalt der QuelleBlack, Joshua, Zachary R. Margolin, Gabrielle Bau, Richard Olson, Janetta L. Iwanicki und Richard C. Dart. „Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study“. JMIR Public Health and Surveillance 7, Nr. 12 (20.12.2021): e29187. http://dx.doi.org/10.2196/29187.
Der volle Inhalt der QuelleKhademi, Sedigh, Christine Mary Hallinan, Mike Conway und Yvonne Bonomo. „Using Social Media Data to Investigate Public Perceptions of Cannabis as a Medicine: Narrative Review“. Journal of Medical Internet Research 25 (27.02.2023): e36667. http://dx.doi.org/10.2196/36667.
Der volle Inhalt der QuelleIvankiv, Ya T. „Micro- and ultrastructural organization of the uterine wall of a white laboratory rat under conditions of 4-week action of Nalbuphine“. Reports of Morphology 26, Nr. 1 (22.05.2020): 32–36. http://dx.doi.org/10.31393/morphology-journal-2020-26(1)-05.
Der volle Inhalt der QuelleArnold, Louise M., Holger Brondke, Katharina Steinitz und Richard J. Kelly. „Monitoring Patient Reported Outcomes in PNH: Interim Results of a Market Research with florio ® PNH“. Blood 142, Supplement 1 (28.11.2023): 7211. http://dx.doi.org/10.1182/blood-2023-185560.
Der volle Inhalt der QuelleWetzel, David A., und Michael D. Tarantino. „Cost-Minimization Analysis of Anti-D Immune Globulin Versus Intravenous Immune Globulin for the Initial Treatment of Immune Thrombocytopenic Purpura.“ Blood 108, Nr. 11 (16.11.2006): 3305. http://dx.doi.org/10.1182/blood.v108.11.3305.3305.
Der volle Inhalt der QuelleDimiccoli, Mariella, und Petia Radeva. „Visual Lifelogging in the Era of Outstanding Digitization“. Digital Presentation and Preservation of Cultural and Scientific Heritage 5 (30.09.2015): 59–64. http://dx.doi.org/10.55630/dipp.2015.5.4.
Der volle Inhalt der QuelleAmundsen, Ellen J., Anne Line Bretteville-Jensen und Ingeborg Rossow. „Patients admitted to treatment for substance use disorder in Norway: a population-based case–control study of socio-demographic correlates and comparative analyses across substance use disorders“. BMC Public Health 22, Nr. 1 (20.04.2022). http://dx.doi.org/10.1186/s12889-022-13199-5.
Der volle Inhalt der QuelleMendell, Ari, Chris Vannabouathong, Kim Le und Peter Dyrda. „Utilization of Opioid Agonist Therapies in Canada“. Canadian Journal of Health Technologies 3, Nr. 8 (15.08.2023). http://dx.doi.org/10.51731/cjht.2023.714.
Der volle Inhalt der QuelleGalvez, Samy J., Frederick L. Altice, Anna Meteliuk, Roman Ivasiy, Eteri Machavariani, Scott O. Farnum, Tetiana Fomenko, Zahedul Islam und Lynn M. Madden. „High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine“. Frontiers in Public Health 11 (30.11.2023). http://dx.doi.org/10.3389/fpubh.2023.1231581.
Der volle Inhalt der QuelleWeleff, Jeremy, Julio C. Nunes, Gabriel P. A. Costa, Mehmet Sofuoglu, R. Ross MacLean und Joao P. De Aquino. „From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder“. British Journal of Clinical Pharmacology, 16.04.2024. http://dx.doi.org/10.1111/bcp.16045.
Der volle Inhalt der QuelleTrammel, Cassandra J., Julia Whitley und Jeannie C. Kelly. „Pharmacotherapy for opioid use disorder in pregnancy“. Current Opinion in Obstetrics & Gynecology, 08.01.2024. http://dx.doi.org/10.1097/gco.0000000000000932.
Der volle Inhalt der QuelleMiller-Rosales, Chris, Susan H. Busch, Ellen R. Meara, Ashleigh King, Thomas A. D’Aunno und Carrie H. Colla. „Internal and Environmental Predictors of Physician Practice Use of Screening and Medications for Opioid Use Disorders“. Medical Care Research and Review, 10.04.2023, 107755872311626. http://dx.doi.org/10.1177/10775587231162681.
Der volle Inhalt der QuelleMcGee, Meghan, Kellia Chiu, Rahim Moineddin und Abhimanyu Sud. „The Impact of Suboxone’s Market Exclusivity on Cost of Opioid Use Disorder Treatment“. Applied Health Economics and Health Policy, 18.01.2023. http://dx.doi.org/10.1007/s40258-022-00787-0.
Der volle Inhalt der QuelleGoyal, Neera K., Erica Sood, Meghan A. Gannon, Grace Harris, Dennis J. Hand, Diane J. Abatemarco und Vanessa L. Short. „Priorities for Well Child Care of Families Affected by Parental Opioid Use Disorder“. Journal of Addiction Medicine, 22.11.2023. http://dx.doi.org/10.1097/adm.0000000000001243.
Der volle Inhalt der QuelleKhataniar, Ripunjoi, und Bobby Hmar. „SOCIO DEMOGRAPHIC AND CLINICAL PROFILE OF INJECTABLE OPIOID ABUSERS IN A HOSPITAL BASED POPULATION“. INDIAN JOURNAL OF APPLIED RESEARCH, 01.08.2022, 77–80. http://dx.doi.org/10.36106/ijar/7203108.
Der volle Inhalt der QuelleJain, Aryan, Annika Dhingra und Aditya Sivakumar. „Opioids and Covid-19: Perfect Storm, or Perfect Opportunity?“ Columbia University Journal of Global Health 13, Nr. 1 (01.05.2023). http://dx.doi.org/10.52214/cujgh.v13i1.10687.
Der volle Inhalt der QuelleMijatović Jovin, Vesna, Isidora Dickov, Dragana Ratković, Aleksandra Dickov und Ana Tomas. „Synthetic cannabinoids awareness among patients with opioid use disorder in Serbia – A survey based cross-sectional pilot study“. Frontiers in Psychiatry 14 (07.03.2023). http://dx.doi.org/10.3389/fpsyt.2023.987726.
Der volle Inhalt der QuelleMariano, Vincent, und Justin Berk. „“Coke in the Dope”: The Underrecognized Complications of a Cocaine-Adulterated Fentanyl Supply“. Journal of Addiction Medicine, 03.06.2024. http://dx.doi.org/10.1097/adm.0000000000001319.
Der volle Inhalt der QuelleHser, Yih-Ing, Allison J. Ober, Alex R. Dopp, Chunqing Lin, Katie P. Osterhage, Sarah E. Clingan, Larissa J. Mooney et al. „Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial“. Addiction Science & Clinical Practice 16, Nr. 1 (20.04.2021). http://dx.doi.org/10.1186/s13722-021-00233-x.
Der volle Inhalt der QuellePage, Sarah, Maria M. Mavrikaki, Tania Lintz, Daniel Puttick, Edward Roberts, Hugh Rosen, F. Ivy Carroll, William A. Carlezon und Elena H. Chartoff. „Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats“. International Journal of Neuropsychopharmacology, 15.10.2019. http://dx.doi.org/10.1093/ijnp/pyz054.
Der volle Inhalt der QuelleMeiselbach, Mark K., Coleman Drake, Jane M. Zhu, Brynna Manibusan, Dylan Nagy, Mark J. Sorbero, Brendan Saloner, Bradley D. Stein und Daniel Polsky. „State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care“. Medical Care Research and Review, 21.04.2023, 107755872311675. http://dx.doi.org/10.1177/10775587231167514.
Der volle Inhalt der QuelleCaulkins, Jonathan P., Anne Gould, Bryce Pardo, Peter Reuter und Bradley D. Stein. „Opioids and the Criminal Justice System: New Challenges Posed by the Modern Opioid Epidemic“. Annual Review of Criminology 4, Nr. 1 (21.09.2020). http://dx.doi.org/10.1146/annurev-criminol-061020-125715.
Der volle Inhalt der QuelleAlmudaifer, Abdullateef I., Whitney Covington, JaMor Hairston, Zachary Deitch, Ankit Anand, Caleb M. Carroll, Estera Crisan et al. „Multi-task transfer learning for the prediction of entity modifiers in clinical text: application to opioid use disorder case detection“. Journal of Biomedical Semantics 15, Nr. 1 (07.06.2024). http://dx.doi.org/10.1186/s13326-024-00311-4.
Der volle Inhalt der Quelle